Suppr超能文献

干姜对乌头碱类生物碱药对中 6 种生物碱药代动力学的影响。

The effects of Rhizoma Zingiberis on pharmacokinetics of six Aconitum alkaloids in herb couple of Radix Aconiti Lateralis-Rhizoma Zingiberis.

机构信息

College of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China.

出版信息

J Ethnopharmacol. 2013 Jul 9;148(2):579-86. doi: 10.1016/j.jep.2013.04.056. Epub 2013 May 22.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Radix Aconiti Lateralis (Fuzi in Chinese, derived from the lateral roots of Aconitum Carmichaeli Debx.) is widely used for the treatment of heart failure, internal cold, arthralgia, diarrhea and edema for thousands of years. It was usually prescribed in combination with Rhizoma Zingiberis (Ganjiang in Chinese, derived from the dry rhizome of Zingiber officinale Rosc.) to decrease toxicity and increase efficacy.

AIM OF THE STUDY

In order to investigate the influence of Rhizoma Zingiberis on pharmacokinetics of six Aconitum alkaloids, i.e. aconitine (AC), hypaconitine (HA), mesaconitine (MA), benzoylaconine (BAC), benzoylhypaconine (BHA) and benzoylmesaconine (BMA), in Fuzi-Ganjiang herb couple, the comparative pharmacokinetics of six Aconitum alkaloids after oral administration of Fuzi and Fuzi-Ganjiang aqueous extract was carried out.

MATERIALS AND METHODS

A sensitive, specific and rapid LC-MS/MS method was developed to determine the six analytes in plasma. Then the rats were randomly divided into two groups and orally administered with Fuzi and Fuzi-Ganjiang aqueous extract. At designated time points after oral administration, the concentrations of the six Aconitum alkaloids in rat plasma were determined, and main pharmacokinetic parameters were investigated using 3P97 (Practical Pharmacokinetics Program Version 1.0).

RESULTS

Comparing with Fuzi group, both T1/2 and AUC0-t of AC and HA decreased (P<0.05), while T1/2, AUC0-t and Cmax of BAC, BHA increased (P<0.05) in Fuzi-Ganjiang group, which indicated that Ganjiang could promote the elimination of AC and HA and enhance the absorption of BAC, BHA and BMA.

CONCLUSION

The differences of pharmacokinetics of Aconitum alkaloids in rat plasma could support those of pharmacologics and toxicity in previous reports between Fuzi and Fuzi-Ganjiang herb couple. The results might be helpful in explaining the mechanism of combination of Fuzi-Ganjiang to decrease toxicity and increase efficacy.

摘要

民族药理学相关性

乌头碱(在中国被称为附子,来源于乌头的侧根)已被广泛用于治疗心力衰竭、内寒、关节炎、腹泻和水肿已有数千年的历史。它通常与姜黄(在中国被称为干姜,来源于姜黄的干燥根茎)联合使用,以降低毒性并提高疗效。

研究目的

为了研究姜黄对附子-姜黄药对中 6 种乌头生物碱(即乌头碱(AC)、次乌头碱(HA)、新乌头碱(MA)、苯甲酰乌头碱(BAC)、苯甲酰次乌头碱(BHA)和苯甲酰新乌头碱(BMA))药代动力学的影响,本研究进行了口服附子和附子-姜黄水提物后 6 种乌头生物碱的比较药代动力学研究。

材料和方法

建立了一种灵敏、特异、快速的 LC-MS/MS 方法,用于测定血浆中的 6 种分析物。然后,将大鼠随机分为两组,分别口服附子和附子-姜黄水提物。口服后指定时间点,测定大鼠血浆中 6 种乌头生物碱的浓度,采用 3P97(实用药代动力学程序版本 1.0)计算主要药代动力学参数。

结果

与附子组相比,附子-姜黄组 AC 和 HA 的 T1/2 和 AUC0-t 均降低(P<0.05),而 BAC、BHA 的 T1/2、AUC0-t 和 Cmax 均升高(P<0.05),表明姜黄能促进 AC 和 HA 的消除,增强 BAC、BHA 和 BMA 的吸收。

结论

大鼠血浆中乌头生物碱药代动力学的差异可以支持附子和附子-姜黄药对之前报道的药理学和毒性差异。研究结果有助于解释附子-姜黄降低毒性、提高疗效的作用机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验